Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prelude Growth Partners is a private, consumer-focused growth equity firm that invests in high-growth branded consumer product and service businesses. The firm provides capital along with strategic and operating support to founders and management teams, with investment interests spanning categories such as health and wellness, beauty and personal care, food and beverage, and consumer services. While some portfolio companies operate in health-adjacent categories, Prelude Growth Partners is not itself a biotech, pharma, or healthcare operating company. As of 2025, the firm reported managing approximately $1.3 billion in assets and closed its third fund, Prelude Growth Partners III, at $600 million.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prelude Growth Partners.